Skip to content

Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate

C19H19N5O3 — CID 121239776

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmethyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate
SMILESCOC(=O)c1cn(C(c2nc3ccccc3[nH]2)C(C)C)cc2c(=O)[nH]nc1-2
InChIInChI=1S/C19H19N5O3/c1-10(2)16(17-20-13-6-4-5-7-14(13)21-17)24-8-11-15(22-23-18(11)25)12(9-24)19(26)27-3/h4-10,16H,1-3H3,(H,20,21)(H,23,25)
InChIKeyRADOJUSAYUVIOG-UHFFFAOYSA-N
MW365.39 g/mol
LogP2.58
Rot. Bonds4

About Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate

Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate (PubChem CID 121239776) has the molecular formula C19H19N5O3 and a molecular weight of 365.39 g/mol. Its IUPAC name is methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate.

Molecular Properties

Compound NameMethyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate
PubChem CID121239776
Molecular FormulaC19H19N5O3
Molecular Weight365.39 g/mol
Exact Mass365.15
IUPAC Namemethyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate
SMILESCOC(=O)c1cn(C(c2nc3ccccc3[nH]2)C(C)C)cc2c(=O)[nH]nc1-2
InChIInChI=1S/C19H19N5O3/c1-10(2)16(17-20-13-6-4-5-7-14(13)21-17)24-8-11-15(22-23-18(11)25)12(9-24)19(26)27-3/h4-10,16H,1-3H3,(H,20,21)(H,23,25)
InChIKeyRADOJUSAYUVIOG-UHFFFAOYSA-N
XLogP2.58
TPSA105.66 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms27
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500365.39
LogP ≤ 52.58
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate?
The IUPAC name of Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate (CID 121239776) is methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate.
What is the SMILES notation for Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate?
The canonical SMILES for Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate is COC(=O)c1cn(C(c2nc3ccccc3[nH]2)C(C)C)cc2c(=O)[nH]nc1-2.
What is the InChIKey of Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate?
The InChIKey is RADOJUSAYUVIOG-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H19N5O3/c1-10(2)16(17-20-13-6-4-5-7-14(13)21-17)24-8-11-15(22-23-18(11)25)12(9-24)19(26)27-3/h4-10,16H,1-3H3,(H,20,21)(H,23,25).
What are the key properties of Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate?
Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate has a molecular weight of 365.39 g/mol, XLogP of 2.58, 4 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for Methyl 5-[1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate is sourced from PubChem (CID 121239776), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.